Baird Medical Investment Holdings Limited announced that its subsidiary, Nanjing Changcheng Medical Equipment Co. Ltd., has received approval of its Single-Use Sterile Biopsy Needle from Jiangsu Medical Products Administration, the drug regulatory body for Jiangsu Province in China. Approved on August 30, 2023, the product is used for biopsies of tumors in superficial tissues located close to the skin surface, such as in breasts, thyroid, and lymph nodes.